Yonsei Med J.  2007 Aug;48(4):609-618. 10.3349/ymj.2007.48.4.609.

DNA Polymorphisms and Haplotypes of Apolipoprotein A5's Attribution to the Plasma Triglyceride Levels in Koreans

• Choi JR
• Nam CM
• Kang DR
• Eom SM
• Lee HJ
• Park CM
• Im JW
• Jang Y

• KMID: 2158165
• DOI: http://doi.org/10.3349/ymj.2007.48.4.609

Abstract

PURPOSE
Recent studies using human and mice reported that apolipoprotein A-V (APOA5) gene plays an important role in controlling triglyceride (TG) concentrations. The purpose of the present study was to investigate the correlation between single nucleotide polymorphisms (SNPs) and haplotypes in the APOA5 gene and TG in subjects and to search for possible associations of the APOA5 gene variants and common haplotypes with hypertriglyceridemia (HTG). MATERIALS AND METHODS: We examined the case-control subjects including 100 HTG patients and 243 unrelated healthy control. The genes were screened for SNPs by direct sequencing in 48 genetically unrelated individuals. Six SNPs (-1390C>T, -1020G>A, -3A>G, V150M, G182C and 1259T>C) were genotyped in case and control populations. RESULTS: In this study, our results indicated a strong association between APOA5 SNP -3A>G and G182C and elevated TG levels (p<0.001). Analysis of the SNPs from APOA5 gene has identified major haplotype showing very strong association with HTG, CGGGTT (p<0.001). Likelihood ratio test (LRT) of these six SNPs revealed that haplotypes were strong independent predictors of HTG (p<0.001). Haplotype-trend logistic regression (HTR) analysis revealed a significant association between the CGGGGC (haplotype 2) and CGGGTT (haplotype 4) and HTG (OR=2.48, 95% CI=1.06-5.76 and OR=8.54, 95% CI=2.66-27.42, respectively). CONCLUSION: We confirm that the APOA5 variants are associated with triglyceride levels and the haplotype may be strong independent predictors of HTG among Koreans.

Keyword

Apolipoprotein A5; case-control study; hypertriglyceridemia; triglyceride

MeSH Terms

Apolipoproteins A/*genetics
Case-Control Studies
Female
Genetic Predisposition to Disease
*Haplotypes
Humans
Hypertriglyceridemia/genetics
Korea
Linkage Disequilibrium
Male
Middle Aged
*Polymorphism, Single Nucleotide
Triglycerides/*blood

Figure

• 

  Fig. 1 APOA5 genomic structure and polymorphism locations. Exons are depicted by boxes in protein-encoding regions with shaded black. The six SNPs used in this analysis are highlighted in bold.

Reference

1. Charlton-Menys V, Durrington PN. Apolipoprotein A5 and hypertriglyceridemia. Clin Chem. 2005. 51:295–297.

2. Wright WT, Young IS, Nicholls DP, Patterson C, Lyttle K, Graham CA. SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population. Atherosclerosis. 2006. 185:353–360.

3. Hsu LA, Ko YL, Chang CJ, Hu CF, Wu S, Teng MS, et al. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis. 2006. 185:143–149.

4. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet. 2002. 11:3031–3038.

5. Dallongeville J, Cottel D, Montaye M, Codron V, Amouyel P, Helbecque N. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int J Cardiol. 2006. 106:152–156.

6. Tang Y, Sun P, Guo D, Ferro A, Ji Y, Chen Q, et al. A genetic variant c.553G>T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis. 2006. 185:433–437.

7. Liu H, Zhang S, Lin J, Li H, Huang A, Xiao C, et al. Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism. 2005. 54:568–572.

8. Austin MA, Talmud PJ, Farin FM, Nickerson DA, Edwards KL, Leonetti D, et al. Association of apolipoprotein A5 variants with LDL particle size and triglyceride in Japanese Americans. Biochim Biophys Acta. 2004. 1688:1–9.

9. Szalai C, Keszei M, Duba J, Prohászka Z, Kozma GT, Császár A, et al. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis. 2004. 173:109–114.

10. Hubácek JA, Adámková V, Ceska R, Poledne R, Horínek A, Vráblík M. New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels. Physiol Res. 2004. 53:225–228.

11. Kao JT, Wen HC, Chien KL, Hsu HC, Lin SW. A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet. 2003. 12:2533–2539.

12. Friedewald WT, Levy RT, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972. 18:449–502.

13. Jang Y, Kim JY, Kim OY, Lee JE, Cho H, Ordovas JM, et al. The -1131T→C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress nonobese Korean men. Am J Clin Nutr. 2004. 80:832–840.

14. Devlin B, Risch N. A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics. 1995. 29:311–322.

15. Zhao JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered. 2000. 50:133–139.

16. Cordell HJ. Estimation and testing of genotype and haplotype effects in case-control studies: comparison of weighted regression and multiple imputation procedures. Genet Epidemiol. 2006. 30:259–275.

17. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001. 294:169–173.

18. Jiang YD, Yen CJ, Chou WL, Kuo SS, Lee KC, Chiu KC, et al. Interaction of the G182C polymorphism in the APOA5 gene and fasting plasma glucose on plasma triglycerides in Type 2 diabetic subjects. Diabet Med. 2005. 22:1690–1695.

19. Zhao SP, Hu S, Li J, Hu M, Liu Q, Wu LJ, et al. Association of human serum apolipoprotein A5 with lipid profiles affected by gender. Clin Chim Acta. 2007. 376:68–71.